KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 131 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,083 | +38.8% | 2,250 | +12.5% | 0.00% | – |
| Q2 2023 | $28,160 | +30.9% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $21,520 | -28.2% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $29,960 | +15.2% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | +36.8% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -5.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | +4.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | -17.9% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -100.0% | 2,000 | -50.0% | 0.00% | -100.0% |
| Q1 2021 | $74,040,000 | +411233.3% | 4,000 | +300.0% | 0.00% | – |
| Q4 2020 | $18,000 | +125.0% | 1,000 | +100.0% | 0.00% | – |
| Q3 2020 | $8,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |